New method to study secondary breast cancer metastasis

December 10, 2013
New method to study secondary breast cancer metastasis

Research led by scientists at King's College London has discovered a new way to study the mechanisms that cause breast cancer cells to spread to the bone.

Although more women than ever before are surviving , 1,000 UK women are still dying from the disease each month. The majority of these deaths are caused by the metastatic form, also known as secondary breast cancer.

Recent discoveries have shown that metastasis (the process of cancer cells leaving the breast and spreading to other parts of the body) may occur early during the development of the disease, with moving around the body before invading tissues and remaining dormant until 'awakened' later on.

An innovative method developed by Dr Gabriela Dontu at the Breakthrough Breast Cancer's Research Unit at King's College London, and published recently in the journal Cancer Research, has revealed significant progress made towards answering this question.

Professor Andrew Tutt, Unit Director explained: 'Working in collaboration with the other scientists at Kings College London, Cancer Research UK and a research team in the US, we have created a new experimental model that can be used to chart forms of tumour cell dormancy. Our model successfully recreates the conditions that cause metastatic to reside in the bone and become dormant enabling us to learn more about, and ultimately hope to prevent, the progression of .'

Dr Matthew Lam, Research Officer at Breakthrough Breast Cancer, said: 'This new method will help scientists unravel the processes that control movement of cancer cells into the bone so it can be detected early which really is the key to stopping metastasis before it takes hold.'

As part of Breakthrough Breast Cancer's new strategy, will become a main focus by working to improve patient experience of those currently living with this form of the disease, campaigning for better access to current treatments and expanding our knowledge of metastases so that we can develop better treatments in the future.

Explore further: Seven new markers discovered for hard-to-treat breast cancer

Related Stories

Seven new markers discovered for hard-to-treat breast cancer

October 25, 2013
(Medical Xpress)—Pioneering research from Breakthrough Breast Cancer scientists has discovered seven molecular markers that contribute to the behaviour of triple negative breast cancers, revealing new insight into this ...

Breast cancer prognosis associated with oncometabolite accumulation

December 9, 2013
The metabolic profile of cancer cells can be used to develop therapies and identify biomarkers associated with cancer outcome. In this issue of the Journal of Clinical Investigation Stefan Ambs and colleagues at the National ...

'Critical gaps' in breast cancer research

October 3, 2013
Critical gaps in breast cancer research could see the loss of around 185,000* lives by 2030 if they are not urgently addressed, according to a major new study co-authored by researchers from King's College London.

Biomarker linked to aggressive breast cancers, poor outcomes in African-Americans

December 8, 2013
Among African-American women with breast cancer, increased levels of the protein HSET were associated with worse breast cancer outcomes, according to results presented here at the Sixth AACR Conference on the Science of Cancer ...

New clues to aggressive breast cancer

November 12, 2013
(Medical Xpress)—Queensland scientists have identified a genetic "switch" which indicates whether a woman's breast cancer will spread.

Recommended for you

Physical activity could combat fatigue, cognitive decline in cancer survivors

July 25, 2017
A new study indicates that cancer patients and survivors have a ready weapon against fatigue and "chemo brain": a brisk walk.

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

No dye: Cancer patients' gray hair darkened on immune drugs

July 21, 2017
Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.